galactosamine has been researched along with nobiletin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akachi, T; Kawagishi, H; Kawaguchi, T; Mori, M; Morita, T; Ohishi, Y; Shiina, Y; Sugiyama, K | 1 |
| Chen, H; Gong, J; He, K; He, Z; Li, X; Liu, Y | 1 |
2 other study(ies) available for galactosamine and nobiletin
| Article | Year |
|---|---|
Hepatoprotective effects of flavonoids from shekwasha (Citrus depressa) against D-galactosamine-induced liver injury in rats.
Topics: Acetaminophen; Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Citrus; DNA Fragmentation; Flavones; Flavonoids; Galactosamine; Lipopolysaccharides; Liver; Male; Molecular Structure; Nitric Oxide; Nitric Oxide Synthase Type II; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; RNA, Messenger; Tumor Necrosis Factor-alpha | 2010 |
Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production.
Topics: Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Cyclooxygenase 2; Cytokines; Flavones; Galactosamine; Gene Expression; Gene Expression Regulation; Heme Oxygenase-1; Lipopolysaccharides; Liver Function Tests; Male; Mice; NF-E2-Related Factor 2; NF-kappa B; Nitric Oxide Synthase Type II; Signal Transduction | 2016 |